The systematic review article is aimed at analysing the economic impact of cardiovascular diseases on migrant labour in Mumbai. During the last decade, there has been a rise in the spread of cardiovascular diseases amongst labour migrants in Mumbai. These rising cases have been looked upon as a growing cause of concern by the government and the policymakers. Changing lifestyle and professional hardships are the detrimental factors for the rising instances of cardiovascular diseases amongst the migrant labour in Mumbai. Thus, this review article seeks to consider the economic impact of rising cardiovascular diseases on the healthcare expenditure of migrant labour in Mumbai from the related literature reviewed. Extensive literature was reviewed from Scopus, Web of Science, Springer and Google Scholar. The eligibility criterion for the literature review was based on the PICO framework (P—Population, I—Intervention, C—Comparison and O—Outcome). Studies available in the English language and indexed in Scopus, Web of Science, Springer and Google Scholar between 2011 and 2021 were considered for review. The result indicates that the median cost of medication spent by a migrant labourer for treatment of cardiovascular diseases in the Mumbai metropolitan region was estimated to be ₹22,049, ₹42,537 being the median cost of hospitalisation and ₹5,411 being the average cost spent on transport to the healthcare facility for the treatment of cardiovascular diseases. This study highlights that the treatment of cardiovascular diseases causes an economic burden on the migrant labour migrating into the Mumbai metropolitan region (MMR) and dwelling in the seven different zones into which the MMR region is divided. The study also suggests the need for the introduction of healthcare schemes to economise the treatment of cardiovascular diseases for migrant labour in the MMR region.
AdsulB. B., LaadP. S., HowalP. V., & ChaturvediR. M. (2011). Health problems among migrant construction workers: A unique public–private partnership project. Indian Journal of Occupational and Environmental Medicine, 15(1), 29–32.
2.
AkariS., MatetiU. V., & KunduruB. R. (2013). Health-care cost in South India: A cost of illness study. Journal of Research in Pharmacy Practice, 2(3), 114–117.
AlbasheerO., AbdelwahabS. I., ZainoM. R., AltraifiA. A. A., HakamiN., El-AminE. I., AlshehriM. M., AlghamdiS. M., AlqahtaniA. S., AlenaziA. M., AlqahtaniB., AlhowimelA., UddinS., KhalafallaH. E. E., & MedaniI. E. (2024). The impact of social isolation and loneliness on cardiovascular disease risk factors: A systematic review, meta-analysis, and bibliometric investigation. Scientific Reports, 14(1), 12871.
5.
BalarajanY., SelvarajS., & SubramaniamS. V. (2011). Health care and equity in India. The Lancet, 377(9764), 505–515. https://doi.org/10.1016/S0140-6736(10)61894-6
6.
BaruaN. (2005, September 12–16). How to develop a pro-poor private health sector in urban India?Paper presented at the Global Forum for Health Research—Forum 9. https://www.researchgate.net/publication/241553007_How_to_develop_a_pro-poor_private_health_sector_in_urban_India
7.
BjorkS., KapurA., KingH., NairJ., & RamachandranA. (2013). Global policy: Aspects of healthcare cost in India. Health Policy, 66(1), 61–72.
8.
ChanB., CoyteP., & HeickC. (1996). Economic impact of cardiovascular disease in Canada. The Canadian Journal of Cardiology, 12(10), 1000–1006.
9.
ChandraP., GogateB., GogateP., ThiteN., MuthaA., & WalimbeA. (2014). Economic burden of healthcare in urban Indians. Open Ophthalmology Journal, 8, 91–94.
10.
CharlesA. K., GrepstadM., VisintinE., & FerrarioA. (2014). The economic burden of healthcare cost in India: A review of the literature. Global Health, 10(8), Article 2.
11.
ChauhanS., & AeriB. T. (2015). The rising incidence of cardiovascular diseases in India: Assessing its economic impact. European Journal of Preventive Cardiology, 4(4), 735–740.
12.
ChoN. H., ShawJ. E., KarurangaS., HuangY., da Rocha FernandesJ. D., OhlroggeA. W., & MalandaB. (2018). IDF Healthcare Atlas: Global estimates of healthcare prevalence for 2017 and projections for 2045. Healthcare Research and Clinical Practice, 138, 271–281.
13.
DhanarajS. (2016). Economic vulnerability to health shocks and coping strategies: Evidence from Andhra Pradesh, India. Health Policy and Planning, 31(6), 749–758.
14.
EinarsonT. R., AcsA., LudwigC., & PantonU. H. (2018). Economic burden of cardiovascular disease in type 2 diabetes: A systematic review. Value in Health, 21(7), 881–890.
15.
GheorgheA., GriffithsU., MurphyA., Legido-QuigleyH., LampteyP., & PerelP. (2018). The economic burden of cardiovascular disease and hypertension in low-and middle-income countries: A systematic review. BMC Public Health, 18(1), 975.
16.
GlynnL. G., ValderasJ. M., HealyP., BurkeE., NewellJ., & GillespieP., . (2011). The prevalence of multi-morbidity in primary care and its effect on health care utilization and cost. Family Practice, 28(5), 516–523.
17.
India State-Level Disease Burden Initiative CVD Collaborators. (2018). The changing patterns of cardiovascular diseases and their risk factors in the states of India: The Global Burden of Disease Study 1990–2016. The Lancet Global Health, 6(12), e1339–e1351.
18.
IyengarS. S., GuptaR., RaviS., ThangamS., AlexanderT., ManjunathC. N., KeshavaR., PatilC. B., SheelaA., & SawhneyJ. P. S. (2017). Premature coronary artery disease in India: Coronary artery disease in the young (CADY) registry. Indian Heart Journal, 69(2), 211–216.
19.
JanB., DarM. I., ChoudharyB., BasistP., KhanR., & AlhalmiA. (2024). Cardiovascular diseases among Indian older adults: A comprehensive review. Cardiovascular Therapeutics, 2024(1), 6894693.
20.
JeemonP., NeogiS., BhatnagarD., CruickshankK. J., & PrabhakaranD. (2009). The impact of migration on cardiovascular disease and its risk factors among people of Indian origin. Current Science, 97(3), 378–384.
21.
KhannaA. (2020). Impact of migration of labour force due to global COVID-19 pandemic with reference to India. Journal of Health Management, 22(2), 181–191.
22.
KhongrangjemT., PhadnisS., & KumarS. (2019). Cost of illness (COI) of type-II diabetes mellitus in Shillong, Meghalaya. International Journal of Diabetes in Developing Countries, 39(1), 201–205.
23.
KhoshakhlaghA. H., MohammadzadehM., Gruszecka-KosowskaA., & OikonomouE. (2024). Burden of cardiovascular disease attributed to air pollution: A systematic review. Globalization and Health, 20(1), 37.
24.
KumarD., & MukherjeeK. (2014). Economic impact of type-2 diabetes mellitus on households in Hisar district of Haryana state, India. The Health Agenda, 2(4), 125–129.
25.
KumpatlaS., KothandanH., TharkarS., & ViswanathanV. (2013). The costs of treating long-term health complications in a developing country: A study from India. Journal of the Association of Physicians of India, 61(1), 1–17.
26.
KunduJ., JamesK. S., HossainB., & ChakrabortyR. (2023). Gender differences in premature mortality for cardiovascular disease in India, 2017–18. BMC Public Health, 23(1), 547.
27.
LauK., AldridgeR., NorredamM., MkomaG. F., KuganM., LinR. C. Y., KissL., ZimmermanC., & HargreavesS. (2024). Workplace mortality risk and social determinants among migrant workers: A systematic review and meta-analysis. The Lancet Public Health, 9(11), e935–e949.
28.
LealJ., Luengo-FernándezR., GrayA., PetersenS., & RaynerM. (2006). Economic burden of cardiovascular diseases in the enlarged European Union. European Heart Journal, 27(13), 1610–1619.
29.
Luengo-FernandezR., LittleM., GrayA., TorbicaA., MaggioniA. P., HuculeciR., TimmisA. D., VardasP., & LealJ. (2024). Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries. European Heart Journal-Quality of Care and Clinical Outcomes, 10(1), 36–44.
30.
MethleyA. M., CampbellS., Chew-GrahamC., McNallyR., & Cheraghi-SohiS. (2014). PICO, PICOS and SPIDER: A comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Services Research, 14(1), 579.
31.
MishraS. R., GhimireS., JoshiC., GyawaliB., ShresthaA., NeupaneD., SharmaS. R., PokharelY., & ViraniS. S. (2019). Cardio-metabolic disease risk factors among South Asian labour migrants to the Middle East: A scoping review and policy analysis. Globalization and Health, 15(1), 33.
32.
MoherD., LiberatiA., TetzlaffJ., & AltmanD. G., & Prisma Group. (2010). https://orcid.org/0000-0000-0000-0000. International Journal of Surgery, 8(5), 336–341.
33.
MolinierL., BauvinE., CombescureC., CastelliC., RebillardX., SouliéM., DaurèsJ. P., & GrosclaudeP. (2008). Methodological considerations in cost of prostate cancer studies: A systematic review. Value in Health, 11(5), 878–885.
34.
MutyambiziC., PavlovaM., CholaL., HongoroC., & GrootW. (2018). Cost of healthcare in Africa: A systematic review of existing literature. Global Health, 14(1), 3.
35.
NgS. W., & PopkinB. M. (2012). Time use and physical activity: A shift away from movement across the globe. Obesity Reviews, 13(8), 659–680.
36.
OommenA. M., AbrahamV. J., GeorgeK., & JoseV. J. (2016). Prevalence of risk factors for non-communicable diseases in rural and urban Tamil Nadu. Indian Journal of Medical Research, 144(3), 460–471.
PereiraE., & PereiraH. (2020). Socioeconomic impact of cardiovascular disease. Revista Portuguesa De Cardiologia (English Edition), 39(5), 253–254.
39.
PrabhakaranD., JeemonP., & RoyA. (2016). Cardiovascular diseases in India: Current epidemiology and future directions. Circulation, 133(16), 1605–1620.
40.
QuintussiM., van de PoelE., PandaP., & RuttenF. (2015). Economic consequences of ill-health for households in northern rural India. BMC Health Services Research, 15, 179. https://doi.org/10.1186/s12913-015-0833-0
41.
RamaiyaK. L., SwaiA. B., McLartyD. G., BhopalR. S., & AlbertiK. G. (1991). Prevalences of diabetes and cardiovascular disease risk factors in Hindu Indian subcommunities in Tanzania. British Medical Journal, 303(6797), 271–276.
42.
RaoG. H. (2018). Cardiometabolic diseases: A global perspective. Journal of Cardiology & Cardiovascular Therapy, 12(2), 555834.
43.
RaoK. D., BhatnagarA., & MurphyA. (2011). Socio-economic inequalities in the financing of cardiovascular and inpatient healthcare treatment in India. Indian Journal of Medical Research, 133(1), 57.
44.
ReddyK. S. (2007). India wakes up to the threat of cardiovascular diseases. Journal of the American College of Cardiology, 50(14), 1370–1372.
45.
Rodriguez-WinB. A., SpruillT. M., & LadapoJ. A. (2013). Economics of psychosocial factors in patients with cardiovascular disease. Progress in Cardiovascular Diseases, 55(6), 563–573.
46.
SatyavaniK., KothandanH., JayaramanM., & ViswanathanV. (2014). Direct costs associated with chronic kidney disease among patients with complications in India. Indian Journal of Nephrology, 24(3), 141–147.
47.
SeedatY. K. (1990). Hypertension and vascular disease in India and migrant Indian populations in the world. Journal of Human Hypertension, 4(4), 421–424.
48.
ShahA., & LercheJ. (2020). Migration and the invisible economies of care: Production, social reproduction and seasonal migrant labour in India. Transactions of the Institute of British Geographers, 45(4), 719–734.
49.
SharmaK. M., RanjaniH., ZabetianA., DattaM., DeepaM., MosesC. A., NarayanK. M. V., MohanV., & AliM. K. (2016). Excess cost burden of healthcare in Southern India: A clinic-based, comparative cost-of-illness study. Global Health Epidemiology and Genomics, 1, e8.
50.
ShrivastavaU., MisraA., MohanV., UnnikrishnanR., & BachaniD. (2017). Obesity, diabetes and cardiovascular diseases in India: Public health challenges. Current Diabetes Reviews, 13(1), 65–80.
51.
SinglaR., BindraJ., SinglaA., GuptaY., & KalraS. (2019). Drug prescription patterns and cost analysis of healthcare therapy in India: Audit of an endocrine practice. Indian Journal of Endocrinology and Metabolism, 23(1), 40–45.
52.
SiqueiraA. D. S. E., Siqueira-FilhoA. G. D., & LandM. G. P. (2017). Analysis of the economic impact of cardiovascular diseases in the last five years in Brazil. Arquivos brasileiros de cardiologia, 109(01), 39–46.
53.
TripathyJ. P., & PrasadB. M. (2018). Cost of healthcare in India: An inequitable picture. Healthcare Metabolic Syndrome Clinical Research Reviews, 12(3), 251–255.
54.
ViswanathanV., & RaoV. N. (2013). Problems associated with healthcare in India. Health Management, 3(1), 31–40.
55.
VolgmanA. S., PalaniappanL. S., AggarwalN. T., GuptaM., KhandelwalA., KrishnanA. V., LichtmanJ. H., MehtaL. S., PatelH. N., ShahK. S., ShahS. H., & WatsonK. E. (2018). Atherosclerotic cardiovascular disease in South Asians in the United States: Epidemiology, risk factors, and treatments: A scientific statement from the American Heart Association. Circulation, 138(1), e1–e34.
